S1-Guideline for Diagnosis and Treatment of Erectile Dysfunction

被引：4

作者：

Haensch, Carl-Albrecht ^{[1
]}

Hilz, Max ^{[2
]}

Jost, Wolfgang ^{[3
]}

Kaufmann, Albert ^{[4
]}

Kessler, Thomas ^{[5
]}

Lahrmann, Heinz

机构：

[1] Kliniken Maria Hilf, Klin Neurol, Viersenerstr 450, D-41063 Monchengladbach, Germany

[2] Univ Erlangen Nurnberg, Klin Neurol, Erlangen, Germany

[3] Parkinson Klin, PKW, Wolfach, Germany

[4] Kliniken Maria Hilf, Zentrum Kontinenz & Neurourol, Monchengladbach, Germany

[5] Univ Balgrist, Zentrum Paraplegie, Zurich, Switzerland

来源：

FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE | 2019年 / 87卷 / 04期

关键词：

Erectile dysfunction; PDE-5; inhibitors; Sexual activity; SEXUAL DYSFUNCTION; INTERNATIONAL INDEX; ORAL SILDENAFIL; CARDIAC RISK; MG; EFFICACY; VARDENAFIL; GUIDELINES; MEN; EPIDEMIOLOGY;

D O I：

10.1055/a-0747-5892

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The S1-Guideline Diagnosis and Therapy of Erectile Dysfunction (Association of the Scientific Medical Societies in Germany (AWMF) registration number 030/112) is available in a completely revised version. Erectile dysfunction (ED) is defined as the persistent or recurrent inability to acquire or sustain an erection of sufficient rigidity and duration for sexual intercourse. There is a high prevalence of ED in the general population in Germany. The frequency of sexual activity decreases with age, and sexual problems become more common with aging. Overall, the prevalence of ED is 2.3% in men 20 to 30 years of age and 53.4% in men in their 7th decade of life. The guideline offers firm recommendations for the diagnosis and treatment of patients suffering from ED. The introduction of new oral therapies has completely changed the diagnostic and therapeutic approach to ED, which is often carried out in a uncritical way.

引用

页码：225 / 233

页数：9

共 52 条

[21] THE MICROARCHITECTURE OF THE INTRACAVERNOSAL SMOOTH-MUSCLE AND THE CAVERNOSAL FIBROUS SKELETON [J].

GOLDSTEIN, AMB ;

PADMANATHAN, H .

JOURNAL OF UROLOGY, 1990, 144 (05) :1144-1146

[22] Oral sildenafil in the treatment of erectile dysfunction [J].

Goldstein, I ;

Lue, TF ;

Padma-Nathan, H ;

Rosen, RC ;

Steers, WD ;

Wicker, PA .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (20) :1397-1404

[23]

Goldstein I, 2002, DIABETES, V51, pA98

[24]

Gresser U, 2002, EUR J MED RES, V7, P435

[25]

Hartmann U, 2000, DTSCH ARZTEBL B, V97, P534

[26] Guidelines on Male Sexual Dysfunction: Erectile Dysfunction and Premature Ejaculation [J].

Hatzimouratidis, Konstantinos ;

Amar, Edouard ;

Eardley, Ian ;

Giuliano, Francois ;

Hatzichristou, Dimitrios ;

Montorsi, Francesco ;

Vardi, Yoram ;

Wespes, Eric .

EUROPEAN UROLOGY, 2010, 57 (05) :804-814

[27] RECOVERY OF ERECTILE FUNCTION BY THE ORAL-ADMINISTRATION OF APOMORPHINE [J].

HEATON, JPW ;

MORALES, A ;

ADAMS, MA ;

JOHNSTON, B ;

ELRASHIDY, R .

UROLOGY, 1995, 45 (02) :200-206

[28] The second princeton consensus on sexual dysfunction and cardiac risk: New guidelines for sexual medicine [J].

Jackson, G ;

Rosen, RC ;

Kloner, RA ;

Kostis, JB .

JOURNAL OF SEXUAL MEDICINE, 2006, 3 (01) :28-36

[29]

Jost WH, 2004, NEUROLOGIE BECKENBOD

[30] SLOWED CONDUCTION IN THE PUDENDAL NERVES IN IDIOPATHIC (NEUROGENIC) FECAL INCONTINENCE [J].

KIFF, ES ;

SWASH, M .

BRITISH JOURNAL OF SURGERY, 1984, 71 (08) :614-616

← 1 2 3 4 5 6 →